Insider trading

Period: 120 months Stock: REGN Role: 10% owners × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

13 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

13 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

13 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

13 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
13 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
13 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

13 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
9 Jun 2020
Sanofi 10% owner · indirect
Sold, plan not stated
$71.84M 120,234 at 597.48
30.1%
29 May 2020
Sanofi 10% owner
Sold, plan not stated
$10.41B 20,421,899 at 509.85
100%
Sold half or more
29 May 2020
Sanofi 10% owner · indirect
Sold, plan not stated
$1.22B 2,399,552 at 509.85
85.7%
Sold half or more
9 Mar 2020
Sanofi 10% owner
Sold, plan not stated
$63.12M 128,914 at 489.65
0.6%
10 Sep 2019
Sanofi 10% owner
Sold, plan not stated
$48.61M 172,904 at 281.15
0.8%
8 Mar 2019
Sanofi 10% owner
Sold, plan not stated
$54.04M 131,115 at 412.17
0.6%
6 Sep 2018
Sanofi 10% owner · indirect
Sold, plan not stated
$42.52M 104,552 at 406.68
0.4%
8 Jun 2018
Sanofi 10% owner · indirect
Sold, plan not stated
$37.61M 121,601 at 309.31
0.5%
25 Aug 2017
Sanofi 10% owner · indirect
Bought 9×
$34.84M 72,378 at 481.36
0.3%
First buy on file
24 Aug 2017
Sanofi 10% owner · indirect
Bought 14×
$51.01M 105,820 at 482.04
0.4%
First buy on file
23 Aug 2017
Sanofi 10% owner · indirect
Bought 5×
$29.02M 60,595 at 478.98
0.3%
First buy on file
2 Jun 2017
Sanofi 10% owner · indirect
Bought 15×
$65.06M 136,050 at 478.17
0.6%
First buy on file
11 Jan 2017
Sanofi 10% owner · indirect
Bought 18×
$32.27M 87,298 at 369.71
0.4%
First buy on file
Showing 1–13 of 13.